Loading interface...

Trilon 40 mg Injection

Manufactured byAJANTA PHARMA LTD
Description
Trilon 40 mg Injection is a corticosteroid which is used to relieve symptoms such as swelling and pain in various conditions such as arthritis, skin disorders, and allergic disorders. This medicine should be used with caution in patients with diabetes and liver and kidney diseases.

Side effects

Major & minor side effects for Trilon 40 mg Injection

  • Anxiety
  • Blurred vision
  • Dizziness
  • Shortness of breath
  • Headache
  • Change in mood
  • Irritability
  • Pounding in ears
  • Numbness, tingling in arms or legs
  • Weight gain
  • Irregular heartbeat

Uses of Trilon 40 mg Injection

What is it prescribed for?

  • Ankylosing Spondylitis
  • Bursitis
  • Rheumatoid Arthritis
  • Gouty arthritis
  • Psoriatic Arthritis
  • Synovitis
  • Lichen simplex chronicus
  • Psoriasis
  • Lichen Planus
  • Keloids
  • Osteoarthritis
  • Multiple sclerosis
  • Allergic Rhinitis
  • Inflammation
  • Alopecia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    After intraarticular, intramuscular or intralesional administration, the effect of this medicine may be observed within 24 to 48 hours depending on the route of administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to triamcinolone, any other inactive ingredients present along with it, or any other corticosteroids.

Systemic infections

This medicine is not recommended for use in patients with systemic infections since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Vaccination

Administration of live or attenuated vaccines is not recommended in patients receiving immunosuppressive doses of this medicine due to the increased risk of serious adverse effects. Your doctor may advise you on an appropriate time gap between the administration of the vaccine and the medicine or suggest an alternative medicine or alternative means of vaccination based on your clinical condition.

Infections

This medicine is not recommended for use in patients suffering from systemic infections since it may worsen the patient's condition. Patients who are at risk of developing infections should be monitored closely during treatment with this medicine for any signs of infections. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Abrupt discontinuation

Do not stop the use of this medicine without consulting your doctor. Abrupt discontinuation may cause withdrawal symptoms such as drowsiness, confusion, headache, fever, etc.

Other uses

Your doctor may prescribe this medicine for indications other than those stated above in certain specific circumstances, especially if other medicines are not effective. All the risks and benefits should be discussed with the doctor in such cases.

Driving or operating machinery

This medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Use in children

This medicine is not recommended for use in patients below 6 years of age since the safety and efficacy of use are not clinically established. However, the doctor may prescribe this medicine if the benefits outweigh the risk. It may cause growth retardation in some children. Therefore, children receiving this medicine should be monitored closely with regard to growth parameters.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. Contact your doctor immediately for further instructions if you miss a scheduled dose of this medicine.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Antidiabetic medicines

Bupropion

Adalimumab

Ketoconazole

Ibuprofen

Disease interactions

Liver Disease

This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Myocardial infarction

This medicine should be used with extreme caution in patients with a history of myocardial infarction due to an increase in the risk of worsening of the patient's condition. Close monitoring of heart function and vital signs is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hyperlipidemia

This medicine should be used with caution in patients with preexisting hyperlipidemia due to an increased risk of elevation in serum triglycerides and LDL cholesterol levels. Close monitoring of triglycerides and cholesterol levels is recommended for these patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Osteoporosis

This medicine should be used with caution in patients with osteoporosis due to an increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney impairment

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Gastrointestinal perforations

This medicine is known to cause perforations and bleeding in the gut especially when high doses are received. Hence this medicine should be administered with caution in patients having a pre-existing perforation disorder of the stomach or intestine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Ocular herpes infection

This medicine should be used with caution if the patient is suffering from an eye infection caused by herpes simplex virus. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Scleroderma

This medicine should be used with caution in patients suffering from this disease where the skin and connective tissue beneath becomes hard and stiff. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Infections

This medicine should be used with extreme caution in patients with latent or active infections since this medicine can suppress the immune system and worsen the patient's condition. This risk is especially higher in patients on high doses of this medicine for a prolonged period of time. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by inhibiting the release of certain chemical substances that cause pain and swelling. It also works by suppressing or partially inhibiting the effect of the immune system.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Glucocorticoids

Schedule

Schedule H

Triamcinolone - DrugBank [Internet]. Drugbank.ca. 2018 [cited 15 January 2018]. Available from:

https://www.drugbank.ca/drugs/DB00620

[Internet]. Accessdata.fda.gov. 2019 [cited 18 September 2019]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012041s045lbl.pdf

Kenalog Intra-articular / Intramuscular Injection - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2019 [cited 18 September 2019]. Available from:

https://www.medicines.org.uk/emc/product/6748/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Oct 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.